Study of Hip Fracture Care for Older Patients

Dr. Rebecca Craik, dean of the College of Health Sciences at Arcadia University discusses a study recently published in JAMA (Sept 2019) in which she was co-PI, that looked at the effects of home-based physical therapy on elderly hip fracture patients.  The study shows that more rigorous physical therapy than what is usually offered can help return the patient to their “before” lifestyle.

Read More

Spinal cord regeneration technology

Dr. Jerry Silver, Professor of Neurosciences at Case Western Reserve University’s School of Medicine and advisor to NervGen Pharma, discusses NervGen Pharma’s spinal cord regeneration technology. In animal studies an injectable peptide, developed by Dr. Silver and NervGen, allowed paralyzed rats to walk again. Phase 1 clinical trials are on the horizon in 2020.

Read More

The “off-the-shelf” approach to gene editing CAR T-cells to treat cancer

Cellectis has pioneered the “off-the-shelf” approach to gene editing CAR T-cells to treat cancer and other genetic diseases. Dr. André Choulika discusses how this approach allows treatments to be produced by the thousands from healthy donor cells (versus the patient’s own cells), stored long-term, provided to hospitals around the world and given to any patient who is in medical need. Off-the-shelf gene editing marks the next transformative step in medicine, and Cellectis has the first U.S. clinical trials underway now.

Read More